APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide CRO Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Peptide CRO Services Market Outlook and Growth Opportunities 2026

23 December 2025215 pages

Choose your research edition.

Industry ResearchPeptide CRO Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide CRO Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Peptide CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide CRO Services Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide CRO Services Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Peptide CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Peptide CRO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Peptide CRO Services market include IMED Bioscience, Peptites Biotech, Genevoyager, Viva Biotech, Space Peptides Pharmaceutical, Motif Biotechnology, JYMed Technology, GenScript and TriApex Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Peptide CRO Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide CRO Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide CRO Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Peptide CRO Services market.

Peptide CRO Services Segment by Company

IMED Bioscience

Peptites Biotech

Genevoyager

Viva Biotech

Space Peptides Pharmaceutical

Motif Biotechnology

JYMed Technology

GenScript

TriApex Laboratories

Go Top Peptide Biotech

Sun-Novo Pharmaceutical Research

Thermo Fisher

Syngene

Svar Life Science

PolyPeptide

PeptiSystems

Peptide Institute

Immunocure

Cusabio

CSBio

CPC Scientific

Buchi

Bachem AG

Aurigene Pharmaceutical Services

AmbioPharm

ABZENA PLC

Peptide CRO Services Segment by Type

Modified Peptide Synthesis

Linear Peptide Synthesis

Cyclic Peptide Synthesis

Others

Peptide CRO Services Segment by Application

Pharmaceutical Companies

Biological Laboratories

Others

Peptide CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Peptide CRO Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Peptide CRO Services key companies, revenue, market share, and recent developments.

3. To split the Peptide CRO Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Peptide CRO Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Peptide CRO Services significant trends, drivers, influence factors in global and regions.

6. To analyze Peptide CRO Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide CRO Services industry.

Chapter 3: Detailed analysis of Peptide CRO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Peptide CRO Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Peptide CRO Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Peptide CRO Services Industry Trends Table 2. Peptide CRO Services Industry Drivers Table 3. Peptide CRO Services Industry Opportunities and Challenges Table 4. Peptide CRO Services Industry Restraints Table 5. Global Peptide CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Peptide CRO Services Revenue Share by Company (2021-2026) Table 7. Global Peptide CRO Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Peptide CRO Services Key Company Manufacturing Base & Headquarters Table 9. Global Peptide CRO Services Company, Product Type & Application Table 10. Global Peptide CRO Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Peptide CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Modified Peptide Synthesis Table 15. Significant Companies of Linear Peptide Synthesis Table 16. Significant Companies of Cyclic Peptide Synthesis Table 17. Significant Companies of Others Table 18. Global Peptide CRO Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Peptide CRO Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Peptide CRO Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Peptide CRO Services Sales Value Share by Type (2021-2026) Table 22. Global Peptide CRO Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Companies Table 24. Significant Companies of Biological Laboratories Table 25. Significant Companies of Others Table 26. Global Peptide CRO Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Peptide CRO Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Peptide CRO Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Peptide CRO Services Sales Value Share by Application (2021-2026) Table 30. Global Peptide CRO Services Sales Value Share by Application (2027-2032) Table 31. Global Peptide CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Peptide CRO Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Peptide CRO Services Sales Value Share by Region (2021-2026) Table 34. Global Peptide CRO Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Peptide CRO Services Sales Value Share by Region (2027-2032) Table 36. Global Peptide CRO Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Peptide CRO Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Peptide CRO Services Sales Value Market Share by Country (2021-2026) Table 39. Global Peptide CRO Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Peptide CRO Services Sales Value Market Share by Country (2027-2032) Table 41. IMED Bioscience Company Information Table 42. IMED Bioscience Business Overview Table 43. IMED Bioscience Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. IMED Bioscience Peptide CRO Services Product Portfolio Table 45. IMED Bioscience Recent Development Table 46. Peptites Biotech Company Information Table 47. Peptites Biotech Business Overview Table 48. Peptites Biotech Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Peptites Biotech Peptide CRO Services Product Portfolio Table 50. Peptites Biotech Recent Development Table 51. Genevoyager Company Information Table 52. Genevoyager Business Overview Table 53. Genevoyager Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Genevoyager Peptide CRO Services Product Portfolio Table 55. Genevoyager Recent Development Table 56. Viva Biotech Company Information Table 57. Viva Biotech Business Overview Table 58. Viva Biotech Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Viva Biotech Peptide CRO Services Product Portfolio Table 60. Viva Biotech Recent Development Table 61. Space Peptides Pharmaceutical Company Information Table 62. Space Peptides Pharmaceutical Business Overview Table 63. Space Peptides Pharmaceutical Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio Table 65. Space Peptides Pharmaceutical Recent Development Table 66. Motif Biotechnology Company Information Table 67. Motif Biotechnology Business Overview Table 68. Motif Biotechnology Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Motif Biotechnology Peptide CRO Services Product Portfolio Table 70. Motif Biotechnology Recent Development Table 71. JYMed Technology Company Information Table 72. JYMed Technology Business Overview Table 73. JYMed Technology Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. JYMed Technology Peptide CRO Services Product Portfolio Table 75. JYMed Technology Recent Development Table 76. GenScript Company Information Table 77. GenScript Business Overview Table 78. GenScript Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GenScript Peptide CRO Services Product Portfolio Table 80. GenScript Recent Development Table 81. TriApex Laboratories Company Information Table 82. TriApex Laboratories Business Overview Table 83. TriApex Laboratories Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. TriApex Laboratories Peptide CRO Services Product Portfolio Table 85. TriApex Laboratories Recent Development Table 86. Go Top Peptide Biotech Company Information Table 87. Go Top Peptide Biotech Business Overview Table 88. Go Top Peptide Biotech Peptide CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Go Top Peptide Biotech Peptide CRO Services Product Portfolio Table 90. Go Top Peptide Biotech Recent Development Table 91. Sun-Novo Pharmaceutical Research Company Information Table 92. Sun-Novo Pharmaceutical Research Business Overview Table 93. Sun-Novo Pharmaceutical Research Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio Table 95. Sun-Novo Pharmaceutical Research Recent Development Table 96. Thermo Fisher Company Information Table 97. Thermo Fisher Business Overview Table 98. Thermo Fisher Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Thermo Fisher Peptide CRO Services Product Portfolio Table 100. Thermo Fisher Recent Development Table 101. Syngene Company Information Table 102. Syngene Business Overview Table 103. Syngene Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Syngene Peptide CRO Services Product Portfolio Table 105. Syngene Recent Development Table 106. Svar Life Science Company Information Table 107. Svar Life Science Business Overview Table 108. Svar Life Science Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Svar Life Science Peptide CRO Services Product Portfolio Table 110. Svar Life Science Recent Development Table 111. PolyPeptide Company Information Table 112. PolyPeptide Business Overview Table 113. PolyPeptide Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. PolyPeptide Peptide CRO Services Product Portfolio Table 115. PolyPeptide Recent Development Table 116. PeptiSystems Company Information Table 117. PeptiSystems Business Overview Table 118. PeptiSystems Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. PeptiSystems Peptide CRO Services Product Portfolio Table 120. PeptiSystems Recent Development Table 121. Peptide Institute Company Information Table 122. Peptide Institute Business Overview Table 123. Peptide Institute Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Peptide Institute Peptide CRO Services Product Portfolio Table 125. Peptide Institute Recent Development Table 126. Immunocure Company Information Table 127. Immunocure Business Overview Table 128. Immunocure Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Immunocure Peptide CRO Services Product Portfolio Table 130. Immunocure Recent Development Table 131. Cusabio Company Information Table 132. Cusabio Business Overview Table 133. Cusabio Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Cusabio Peptide CRO Services Product Portfolio Table 135. Cusabio Recent Development Table 136. CSBio Company Information Table 137. CSBio Business Overview Table 138. CSBio Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. CSBio Peptide CRO Services Product Portfolio Table 140. CSBio Recent Development Table 141. CPC Scientific Company Information Table 142. CPC Scientific Business Overview Table 143. CPC Scientific Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. CPC Scientific Peptide CRO Services Product Portfolio Table 145. CPC Scientific Recent Development Table 146. Buchi Company Information Table 147. Buchi Business Overview Table 148. Buchi Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Buchi Peptide CRO Services Product Portfolio Table 150. Buchi Recent Development Table 151. Bachem AG Company Information Table 152. Bachem AG Business Overview Table 153. Bachem AG Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Bachem AG Peptide CRO Services Product Portfolio Table 155. Bachem AG Recent Development Table 156. Aurigene Pharmaceutical Services Company Information Table 157. Aurigene Pharmaceutical Services Business Overview Table 158. Aurigene Pharmaceutical Services Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio Table 160. Aurigene Pharmaceutical Services Recent Development Table 161. AmbioPharm Company Information Table 162. AmbioPharm Business Overview Table 163. AmbioPharm Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. AmbioPharm Peptide CRO Services Product Portfolio Table 165. AmbioPharm Recent Development Table 166. ABZENA PLC Company Information Table 167. ABZENA PLC Business Overview Table 168. ABZENA PLC Peptide CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. ABZENA PLC Peptide CRO Services Product Portfolio Table 170. ABZENA PLC Recent Development Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Peptide CRO Services Product Image Figure 2. Global Peptide CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Peptide CRO Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Modified Peptide Synthesis Image Figure 8. Linear Peptide Synthesis Image Figure 9. Cyclic Peptide Synthesis Image Figure 10. Others Image Figure 11. Global Peptide CRO Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Peptide CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Peptide CRO Services Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Companies Image Figure 15. Biological Laboratories Image Figure 16. Others Image Figure 17. Global Peptide CRO Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Peptide CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Peptide CRO Services Sales Value Share by Application (2021-2032) Figure 20. Global Peptide CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Peptide CRO Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Peptide CRO Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Peptide CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Peptide CRO Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Peptide CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Peptide CRO Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Peptide CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Peptide CRO Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Peptide CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Peptide CRO Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Peptide CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Peptide CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Peptide CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Peptide CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Modified Peptide Synthesis
  • Linear Peptide Synthesis
  • Cyclic Peptide Synthesis
  • Others
Applications
  • Pharmaceutical Companies
  • Biological Laboratories
  • Others
Companies covered
  • IMED Bioscience
  • Peptites Biotech
  • Genevoyager
  • Viva Biotech
  • Space Peptides Pharmaceutical
  • Motif Biotechnology
  • JYMed Technology
  • GenScript
  • TriApex Laboratories
  • Go Top Peptide Biotech
  • Sun-Novo Pharmaceutical Research
  • Thermo Fisher
  • Syngene
  • Svar Life Science
  • PolyPeptide
  • PeptiSystems
  • Peptide Institute
  • Immunocure
  • Cusabio
  • CSBio
  • CPC Scientific
  • Buchi
  • Bachem AG
  • Aurigene Pharmaceutical Services
  • AmbioPharm
  • ABZENA PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Peptide CRO Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Peptide CRO Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Peptide CRO Services Market Dynamics
  1. 2.1 Peptide CRO Services Industry Trends
  2. 2.2 Peptide CRO Services Industry Drivers
  3. 2.3 Peptide CRO Services Industry Opportunities and Challenges
  4. 2.4 Peptide CRO Services Industry Restraints
3 Peptide CRO Services Market by Company
  1. 3.1 Global Peptide CRO Services Company Revenue Ranking in 2025
  2. 3.2 Global Peptide CRO Services Revenue by Company (2021-2026)
  3. 3.3 Global Peptide CRO Services Company Ranking (2024-2026)
  4. 3.4 Global Peptide CRO Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Peptide CRO Services Company Product Type and Application
  6. 3.6 Global Peptide CRO Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Peptide CRO Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Peptide CRO Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Peptide CRO Services Market by Type
  1. 4.1 Peptide CRO Services Type Introduction
  2. 4.1.1 Modified Peptide Synthesis
  3. 4.1.2 Linear Peptide Synthesis
  4. 4.1.3 Cyclic Peptide Synthesis
  5. 4.1.4 Others
  6. 4.2 Global Peptide CRO Services Sales Value by Type
  7. 4.2.1 Global Peptide CRO Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Peptide CRO Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Peptide CRO Services Sales Value Share by Type (2021-2032)
5 Peptide CRO Services Market by Application
  1. 5.1 Peptide CRO Services Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Biological Laboratories
  4. 5.1.3 Others
  5. 5.2 Global Peptide CRO Services Sales Value by Application
  6. 5.2.1 Global Peptide CRO Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peptide CRO Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Peptide CRO Services Sales Value Share by Application (2021-2032)
6 Peptide CRO Services Regional Value Analysis
  1. 6.1 Global Peptide CRO Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peptide CRO Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Peptide CRO Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Peptide CRO Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Peptide CRO Services Sales Value (2021-2032)
  7. 6.3.2 North America Peptide CRO Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Peptide CRO Services Sales Value (2021-2032)
  10. 6.4.2 Europe Peptide CRO Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Peptide CRO Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Peptide CRO Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Peptide CRO Services Sales Value (2021-2032)
  16. 6.6.2 South America Peptide CRO Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Peptide CRO Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Peptide CRO Services Sales Value Share by Country, 2025 VS 2032
7 Peptide CRO Services Country-level Value Analysis
  1. 7.1 Global Peptide CRO Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Peptide CRO Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Peptide CRO Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Peptide CRO Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Peptide CRO Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Peptide CRO Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Peptide CRO Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Peptide CRO Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Peptide CRO Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Peptide CRO Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Peptide CRO Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Peptide CRO Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Peptide CRO Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Peptide CRO Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Peptide CRO Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Peptide CRO Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Peptide CRO Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Peptide CRO Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Peptide CRO Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Peptide CRO Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Peptide CRO Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Peptide CRO Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Peptide CRO Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Peptide CRO Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Peptide CRO Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Peptide CRO Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Peptide CRO Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Peptide CRO Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Peptide CRO Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Peptide CRO Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Peptide CRO Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Peptide CRO Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Peptide CRO Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Peptide CRO Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IMED Bioscience
  2. 8.1.1 IMED Bioscience Company Information
  3. 8.1.2 IMED Bioscience Business Overview
  4. 8.1.3 IMED Bioscience Peptide CRO Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IMED Bioscience Peptide CRO Services Product Portfolio
  6. 8.1.5 IMED Bioscience Recent Developments
  7. 8.2 Peptites Biotech
  8. 8.2.1 Peptites Biotech Company Information
  9. 8.2.2 Peptites Biotech Business Overview
  10. 8.2.3 Peptites Biotech Peptide CRO Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Peptites Biotech Peptide CRO Services Product Portfolio
  12. 8.2.5 Peptites Biotech Recent Developments
  13. 8.3 Genevoyager
  14. 8.3.1 Genevoyager Company Information
  15. 8.3.2 Genevoyager Business Overview
  16. 8.3.3 Genevoyager Peptide CRO Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genevoyager Peptide CRO Services Product Portfolio
  18. 8.3.5 Genevoyager Recent Developments
  19. 8.4 Viva Biotech
  20. 8.4.1 Viva Biotech Company Information
  21. 8.4.2 Viva Biotech Business Overview
  22. 8.4.3 Viva Biotech Peptide CRO Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Viva Biotech Peptide CRO Services Product Portfolio
  24. 8.4.5 Viva Biotech Recent Developments
  25. 8.5 Space Peptides Pharmaceutical
  26. 8.5.1 Space Peptides Pharmaceutical Company Information
  27. 8.5.2 Space Peptides Pharmaceutical Business Overview
  28. 8.5.3 Space Peptides Pharmaceutical Peptide CRO Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio
  30. 8.5.5 Space Peptides Pharmaceutical Recent Developments
  31. 8.6 Motif Biotechnology
  32. 8.6.1 Motif Biotechnology Company Information
  33. 8.6.2 Motif Biotechnology Business Overview
  34. 8.6.3 Motif Biotechnology Peptide CRO Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Motif Biotechnology Peptide CRO Services Product Portfolio
  36. 8.6.5 Motif Biotechnology Recent Developments
  37. 8.7 JYMed Technology
  38. 8.7.1 JYMed Technology Company Information
  39. 8.7.2 JYMed Technology Business Overview
  40. 8.7.3 JYMed Technology Peptide CRO Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JYMed Technology Peptide CRO Services Product Portfolio
  42. 8.7.5 JYMed Technology Recent Developments
  43. 8.8 GenScript
  44. 8.8.1 GenScript Company Information
  45. 8.8.2 GenScript Business Overview
  46. 8.8.3 GenScript Peptide CRO Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GenScript Peptide CRO Services Product Portfolio
  48. 8.8.5 GenScript Recent Developments
  49. 8.9 TriApex Laboratories
  50. 8.9.1 TriApex Laboratories Company Information
  51. 8.9.2 TriApex Laboratories Business Overview
  52. 8.9.3 TriApex Laboratories Peptide CRO Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TriApex Laboratories Peptide CRO Services Product Portfolio
  54. 8.9.5 TriApex Laboratories Recent Developments
  55. 8.10 Go Top Peptide Biotech
  56. 8.10.1 Go Top Peptide Biotech Company Information
  57. 8.10.2 Go Top Peptide Biotech Business Overview
  58. 8.10.3 Go Top Peptide Biotech Peptide CRO Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Go Top Peptide Biotech Peptide CRO Services Product Portfolio
  60. 8.10.5 Go Top Peptide Biotech Recent Developments
  61. 8.11 Sun-Novo Pharmaceutical Research
  62. 8.11.1 Sun-Novo Pharmaceutical Research Company Information
  63. 8.11.2 Sun-Novo Pharmaceutical Research Business Overview
  64. 8.11.3 Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio
  66. 8.11.5 Sun-Novo Pharmaceutical Research Recent Developments
  67. 8.12 Thermo Fisher
  68. 8.12.1 Thermo Fisher Company Information
  69. 8.12.2 Thermo Fisher Business Overview
  70. 8.12.3 Thermo Fisher Peptide CRO Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Peptide CRO Services Product Portfolio
  72. 8.12.5 Thermo Fisher Recent Developments
  73. 8.13 Syngene
  74. 8.13.1 Syngene Company Information
  75. 8.13.2 Syngene Business Overview
  76. 8.13.3 Syngene Peptide CRO Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Syngene Peptide CRO Services Product Portfolio
  78. 8.13.5 Syngene Recent Developments
  79. 8.14 Svar Life Science
  80. 8.14.1 Svar Life Science Company Information
  81. 8.14.2 Svar Life Science Business Overview
  82. 8.14.3 Svar Life Science Peptide CRO Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Svar Life Science Peptide CRO Services Product Portfolio
  84. 8.14.5 Svar Life Science Recent Developments
  85. 8.15 PolyPeptide
  86. 8.15.1 PolyPeptide Company Information
  87. 8.15.2 PolyPeptide Business Overview
  88. 8.15.3 PolyPeptide Peptide CRO Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PolyPeptide Peptide CRO Services Product Portfolio
  90. 8.15.5 PolyPeptide Recent Developments
  91. 8.16 PeptiSystems
  92. 8.16.1 PeptiSystems Company Information
  93. 8.16.2 PeptiSystems Business Overview
  94. 8.16.3 PeptiSystems Peptide CRO Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 PeptiSystems Peptide CRO Services Product Portfolio
  96. 8.16.5 PeptiSystems Recent Developments
  97. 8.17 Peptide Institute
  98. 8.17.1 Peptide Institute Company Information
  99. 8.17.2 Peptide Institute Business Overview
  100. 8.17.3 Peptide Institute Peptide CRO Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Peptide Institute Peptide CRO Services Product Portfolio
  102. 8.17.5 Peptide Institute Recent Developments
  103. 8.18 Immunocure
  104. 8.18.1 Immunocure Company Information
  105. 8.18.2 Immunocure Business Overview
  106. 8.18.3 Immunocure Peptide CRO Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Immunocure Peptide CRO Services Product Portfolio
  108. 8.18.5 Immunocure Recent Developments
  109. 8.19 Cusabio
  110. 8.19.1 Cusabio Company Information
  111. 8.19.2 Cusabio Business Overview
  112. 8.19.3 Cusabio Peptide CRO Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cusabio Peptide CRO Services Product Portfolio
  114. 8.19.5 Cusabio Recent Developments
  115. 8.20 CSBio
  116. 8.20.1 CSBio Company Information
  117. 8.20.2 CSBio Business Overview
  118. 8.20.3 CSBio Peptide CRO Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CSBio Peptide CRO Services Product Portfolio
  120. 8.20.5 CSBio Recent Developments
  121. 8.21 CPC Scientific
  122. 8.21.1 CPC Scientific Company Information
  123. 8.21.2 CPC Scientific Business Overview
  124. 8.21.3 CPC Scientific Peptide CRO Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 CPC Scientific Peptide CRO Services Product Portfolio
  126. 8.21.5 CPC Scientific Recent Developments
  127. 8.22 Buchi
  128. 8.22.1 Buchi Company Information
  129. 8.22.2 Buchi Business Overview
  130. 8.22.3 Buchi Peptide CRO Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Buchi Peptide CRO Services Product Portfolio
  132. 8.22.5 Buchi Recent Developments
  133. 8.23 Bachem AG
  134. 8.23.1 Bachem AG Company Information
  135. 8.23.2 Bachem AG Business Overview
  136. 8.23.3 Bachem AG Peptide CRO Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Bachem AG Peptide CRO Services Product Portfolio
  138. 8.23.5 Bachem AG Recent Developments
  139. 8.24 Aurigene Pharmaceutical Services
  140. 8.24.1 Aurigene Pharmaceutical Services Company Information
  141. 8.24.2 Aurigene Pharmaceutical Services Business Overview
  142. 8.24.3 Aurigene Pharmaceutical Services Peptide CRO Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio
  144. 8.24.5 Aurigene Pharmaceutical Services Recent Developments
  145. 8.25 AmbioPharm
  146. 8.25.1 AmbioPharm Company Information
  147. 8.25.2 AmbioPharm Business Overview
  148. 8.25.3 AmbioPharm Peptide CRO Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 AmbioPharm Peptide CRO Services Product Portfolio
  150. 8.25.5 AmbioPharm Recent Developments
  151. 8.26 ABZENA PLC
  152. 8.26.1 ABZENA PLC Company Information
  153. 8.26.2 ABZENA PLC Business Overview
  154. 8.26.3 ABZENA PLC Peptide CRO Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 ABZENA PLC Peptide CRO Services Product Portfolio
  156. 8.26.5 ABZENA PLC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst